BACKGROUND: Both renal dysfunction and left ventricular hypertrophy (LVH) are signs of end-organ damage, risk markers of cardiovascular (CV) disease and chronic heart failure. In selected populations such as those with diabetes or hypertension, renal dysfunction was found to be related to LVH. We studied the relation between renal dysfunction and LVH in a cross-sectional study in 8592 inhabitants from Groningen, The Netherlands. METHODS: Standard 12-lead electrocardiograms were recorded, and LVH was classified using the Cornell voltage duration product. Renal dysfunction was defined as creatinine clearance <60 mL/min/1.73 m(2) or microalbuminuria (30 to 300 mg/24 h). RESULTS: Electrocardiographic signs of LVH were present in 396 of subjects (5.3%). Subjects with LVH were older and had a more extensive CV risk profile. We found that LVH was more prevalent in subjects with renal dysfunction than in those without (8% v 4%, P < .001). Multivariate regression analysis demonstrated that renal dysfunction was independently related to a 1.47-fold increased risk of the presence of LVH (95% CI = 1.15 to 1.88, P = .009). In addition, both creatinine clearance (OR = 1.56, 95% CI = 1.07 to 2.2, P = .044) and microalbuminuria (OR = 1.37, 95% CI = 1.04 to 1.80, P = .024) were independently associated with the presence of LVH. CONCLUSION: Subjects with mild renal dysfunction have a substantially higher risk of LVH on electrocardiography than those without renal dysfunction.
BACKGROUND: Both renal dysfunction and left ventricular hypertrophy (LVH) are signs of end-organ damage, risk markers of cardiovascular (CV) disease and chronic heart failure. In selected populations such as those with diabetes or hypertension, renal dysfunction was found to be related to LVH. We studied the relation between renal dysfunction and LVH in a cross-sectional study in 8592 inhabitants from Groningen, The Netherlands. METHODS: Standard 12-lead electrocardiograms were recorded, and LVH was classified using the Cornell voltage duration product. Renal dysfunction was defined as creatinine clearance <60 mL/min/1.73 m(2) or microalbuminuria (30 to 300 mg/24 h). RESULTS: Electrocardiographic signs of LVH were present in 396 of subjects (5.3%). Subjects with LVH were older and had a more extensive CV risk profile. We found that LVH was more prevalent in subjects with renal dysfunction than in those without (8% v 4%, P < .001). Multivariate regression analysis demonstrated that renal dysfunction was independently related to a 1.47-fold increased risk of the presence of LVH (95% CI = 1.15 to 1.88, P = .009). In addition, both creatinine clearance (OR = 1.56, 95% CI = 1.07 to 2.2, P = .044) and microalbuminuria (OR = 1.37, 95% CI = 1.04 to 1.80, P = .024) were independently associated with the presence of LVH. CONCLUSION: Subjects with mild renal dysfunction have a substantially higher risk of LVH on electrocardiography than those without renal dysfunction.
Authors: C A Geluk; R A Tio; J G P Tijssen; R B van Dijk; W A Dijk; H L Hillege; P E de Jong; W H van Gilst; F Zijlstra Journal: Neth Heart J Date: 2007 Impact factor: 2.380
Authors: F W Asselbergs; M P van den Berg; S J Bakker; J E Signorovitch; H L Hillege; W H van Gilst; D J van Veldhuisen Journal: Neth Heart J Date: 2008 Impact factor: 2.380
Authors: Sonia Shah; Christopher P Nelson; Tom R Gaunt; Pim van der Harst; Timothy Barnes; Peter S Braund; Debbie A Lawlor; Juan-Pablo Casas; Sandosh Padmanabhan; Fotios Drenos; Mika Kivimaki; Philippa J Talmud; Steve E Humphries; John Whittaker; Richard W Morris; Peter H Whincup; Anna Dominiczak; Patricia B Munroe; Toby Johnson; Alison H Goodall; Francois Cambien; Patrick Diemert; Christian Hengstenberg; Willem H Ouwehand; Janine F Felix; Nicole L Glazer; Maciej Tomaszewski; Paul R Burton; Martin D Tobin; Dirk J van Veldhuisen; Rudolf A de Boer; Gerjan Navis; Wiek H van Gilst; Bongani M Mayosi; John R Thompson; Meena Kumari; Peter W MacFarlane; Ian N M Day; Aroon D Hingorani; Nilesh J Samani Journal: Circ Cardiovasc Genet Date: 2011-09-30
Authors: Folkert W Asselbergs; Jason H Moore; Maarten P van den Berg; Eric B Rimm; Rudolf A de Boer; Robin P Dullaart; Gerjan Navis; Wiek H van Gilst Journal: BMC Med Genet Date: 2006-04-19 Impact factor: 2.103
Authors: Christiane A Geluk; Riksta Dikkers; Jan A Kors; René A Tio; Riemer H J A Slart; Rozemarijn Vliegenthart; Hans L Hillege; Tineke P Willems; Paul E de Jong; Wiek H van Gilst; Matthijs Oudkerk; Felix Zijlstra Journal: BMC Cardiovasc Disord Date: 2007-07-13 Impact factor: 2.298
Authors: Niels Grote Beverborg; Niek Verweij; Ijsbrand T Klip; Haye H van der Wal; Adriaan A Voors; Dirk J van Veldhuisen; Ron T Gansevoort; Stephan J L Bakker; Pim van der Harst; Peter van der Meer Journal: PLoS One Date: 2015-04-27 Impact factor: 3.240